Supplements

Cancer Data Trends 2022


 

Federal Practitioner, in collaboration with the Association of VA Hematology/Oncology (AVAHO), present the 2022 edition of Cancer Data Trends (click to view the digital edition). This special issue provides updates on some of the top cancers and related concerns affecting veterans through original infographics and visual storytelling.

In this issue:

Federal Practitioner and AVAHO would like to thank the following experts for their contributions to this issue:

Anita Aggarwal, DO, PhD; Sara Ahmed, PhD; Katherine Faricy-Anderson, MD; Apar Kishor Ganti, MD, MS; Solomon A Graf, MD; Kate Hendricks Thomas, PhD; Michael Kelley, MD; Mark Klein, MD, Gina McWhirter, MSN, MBA, RN; Bruce Montgomery, MD; Vida Almario Passero, MD, MBA; Thomas D Rodgers, MD; Vlad C Sandulache, MD, PhD; David H Wang, MD, PhD.

Recommended Reading

Adverse skin effects of cancer immunotherapy reviewed
Federal Practitioner
FDA approves new immunotherapy combo for metastatic melanoma
Federal Practitioner
Complex surgery 10 times more likely with some ovarian tumors
Federal Practitioner
Symptoms, not pelvic exams, pick up most endometrial cancer recurrences
Federal Practitioner
Few new cancer drugs replace current standards of care
Federal Practitioner
Breast density linked to familial breast cancer risk
Federal Practitioner
Rise in oral cancers among young nonsmokers points to immunodeficiency
Federal Practitioner
Immunotherapy treatment shows promise for resectable liver cancer
Federal Practitioner
Two leading oral cancer treatment guidelines differ on recurrence and survival predictions
Federal Practitioner
Cancer survivors: Move more, sit less for a longer life, study says
Federal Practitioner